Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, St Louis MO
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07137416
Phase1, Recruiting
Hypnosis in Treating Hot Flashes in Breast Cancer Survivors
for
Breast Cancer, Cancer Survivor, Hot Flashes
Location: Temple TX
Sponsor: Scott and White Hospital & Clinic
Sex: Female
Age: 18+
Code: NCT00094133
Recruiting
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
for
Metastatic Breast Cancer
Location: Houston TX, Gilbert AZ
Sponsor: Adherex Technologies, Inc.
Sex: Female
Age: 18+
Code: NCT01231802
Phase2, Recruiting
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
for
Breast Cancer, Node-positive Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06833502
Phase2, Recruiting
Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women
for
Stage I Breast Cancer
Location: Burlington VT
Sponsor: University of Vermont
Sex: Female
Age: 65+
Code: NCT00337064
Phase1, Phase2, Recruiting
Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology
for
Breast Cancer
Location: Madison WI
Sponsor: LumaMed
Sex: Female
Age: 18 - 70
Code: NCT02207179
Early_phase1, Recruiting
A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer
for
Breast Cancer, Invasive Breast Cancer
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute
Sex: Female
Age: 18+
Code: NCT02333890
Phase2, Recruiting
Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer
for
Breast Cancer
Location: Durham NC
Sponsor: National Center for Research Resources (NCRR)
Sex: Female
Age: 18 - 70+
Code: NCT00006433
Phase2, Recruiting
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
for
Early-stage Breast Cancer,
Location: Boston MA, Wichita KS, Fullerton CA, Whittier CA,
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT04553770
Phase2, Recruiting
Behavioral Weight Loss and Exercise After Treatment (BEAT)
for
Breast Cancer
Location: Burlington VT
Sponsor: University of Vermont
Sex: All
Age: 21 - 69
Code: NCT02052115
Recruiting
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
for
Lymphedema, Lymphedema, Breast Cancer, Lymphedema Arm
Location: Palo Alto CA
Sponsor: Koya Medical, Inc.
Sex: All
Age: 18+
Code: NCT04888975
Recruiting
A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer
for
Metastatic Breast Cancer
Location: Mobile AL
Sponsor: Southern Cancer Center
Sex: Female
Age: 18 - 70+
Code: NCT00715832
Phase1, Recruiting
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
for
Breast Cancer
Location: Raleigh NC, Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT03769415
Recruiting
New
Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial